Guaijaverin

CAS No. 22255-13-6

Guaijaverin( —— )

Catalog No. M18254 CAS No. 22255-13-6

Guaijaverin is a urease inhibitor with antibacterial activity against Strep. mutans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 178 In Stock
10MG 263 In Stock
25MG 443 In Stock
50MG 645 In Stock
100MG 888 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Guaijaverin
  • Note
    Research use only, not for human use.
  • Brief Description
    Guaijaverin is a urease inhibitor with antibacterial activity against Strep. mutans.
  • Description
    Guaijaverin is a urease inhibitor. Guaijaverin has antioxidant activity. Guaijaverin has antibacterial activity against Strep. mutans.
  • In Vitro
    Guaijaverin has anti-Strep.mutans activity, with MIC values of 4 and 2 mg/ml for MTCC 1943 and CLSM 001 strain of Strep. mutans, respectively.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Caspase
  • Recptor
    Antioxidant|urease inhibitor
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    22255-13-6
  • Formula Weight
    434.35
  • Molecular Formula
    C20H18O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (230.23 mM)
  • SMILES
    C1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chelidonic acid

    Chelidonic acid is a component of Chelidonium majus L. used as a mild analgesic an antimicrobial?an acentral nervous system sedative. Chelidonic acid also shows anti-inflammatory activity.

  • Estramustine phospha...

    Estramustine phosphate sodium is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle.

  • IDN-7314

    A potent, orally active, and irreversible pan-Caspase protease inhibitor with IC50 of <0.08 to 7 nM for inhibition of activated caspase 3, 6 and 8.